LTRN
Lantern PharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LTRN Profile
Lantern Pharma Inc.
A clinical stage biopharmaceutical company that develops oncology-based therapeutics for the treatment of cancer
Biological Technology
11/07/2013
06/11/2020
NASDAQ Stock Exchange
24
12-31
Common stock
1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201
--
Lantern Pharma Inc., was founded on November 7, 2013. The company is a clinical-stage biotechnology company that leverages artificial intelligence (" A.I. "), machine learning and genomic data to simplify drug development processes and enable patients to be treated to benefit from its targeted tumor therapies.
